Skin
Skin
- The skin is the largest organ system in the body.
- Comprises 10-15% of body weight.
- Receives 1/3 of circulating blood volume, indicating its importance.
- Functions:
- Protective barrier against the external environment.
- Maintains water balance.
- Regulates temperature.
Pressure Injuries
- Occur when the skin's vascular supply is compromised.
- Definition: Localized injury to the skin and underlying tissue, usually over a bony prominence.
- Cause: Pressure or pressure combined with shear.
- Common Sites:
- Sacrum and heels (most common).
- Occiput in young children (due to proportionally larger head size).
- Influencing Factors:
- Amount of pressure applied.
- Duration of pressure.
- Tissue's ability to tolerate shearing force (pressure exerted when surface layer adheres to bedding while deeper layers slide).
- Risk Factors:
- Immobility.
- Excessive moisture (e.g., incontinence).
- Inadequate nutrition.
- Medical devices (device-related pressure injuries).
- Examples: face masks, trach tubes/ties, endotracheal tubes, oxygen cannulas, monitoring probes.
- Skin Failure:
- Distinct from pressure injuries but interrelated.
- May occur simultaneously with pressure injuries in critically ill children due to multiple organ dysfunction syndrome (MODS).
- Blood is shunted away from the skin to protect vital organs.
- Associated with hemodynamic changes:
- Pale, cool skin.
- Poor capillary refill.
- Impaired thermoregulatory control.
- Metabolic complications (e.g., acidosis).
- Pressure injuries preventable; injuries from skin failure may not be.
Clinical Manifestations (Staging) of Pressure Injuries
- Staged based on visible/palpable tissue in the injury bed.
- Stage 1:
- Intact skin with non-blanchable erythema (redness).
- Localized area, usually over a bony prominence.
- Stage 2:
- Partial thickness loss of dermis.
- Red-pink wound bed without slough.
- Stage 3:
- Full thickness skin loss.
- Subcutaneous fat may be visible.
- Bone, tendon, or muscle are not exposed.
- Stage 4:
- Full thickness tissue loss.
- Exposed bone, tendon, or muscle.
- Slough or eschar may be present.
- May include undermining and tunneling.
- Unstageable:
- Full thickness tissue loss, but depth obscured by slough or eschar.
- Suspected Deep Tissue Injury:
- Purple or maroon localized area of discolored intact skin or blood-filled blister.
- Damage to underlying soft tissue from pressure or shear.
Pressure Injury Prevention
- Perform thorough skin and risk assessment on admission and each shift, using a validated tool (e.g., Braden QD scale considering device-related risks).
- Keep skin clean and dry, especially perineal and perianal areas.
- Ensure adequate nutrition.
- Apply preventative dressings over bony prominences.
- Relieve pressure through frequent repositioning (even small changes are beneficial).
- Avoid wrinkles under the patient.
- Use appropriate mattress surfaces (low air loss or alternating pressure).
- Be aware of medical devices and rotate them to different sites when possible.
IV Infiltration
- Definition: Leakage of IV fluids or medications into surrounding tissue.
- Causes: Improper catheter placement or dislodgement, patient movement.
- Prevention:
- Select appropriate IV site (avoid flexion areas).
- Follow hospital policies for securing the IV catheter.
- Observe IV site frequently.
- Instruct patient to report swelling or tenderness.
- Signs/Symptoms:
- Swelling.
- Discomfort.
- Burning.
- Tightness.
- Cool skin.
- Blanching.
- Management:
- Stop infusion and remove device.
- Elevate limb.
- Apply cold or warm compress.
- Monitor pulse and capillary refill time.
- Assess site frequently.
- Document findings and interventions.
Extravasation
- Definition: Leakage of vesicant drugs into surrounding tissue.
- Consequences: Severe local tissue damage, delayed healing, infection, tissue necrosis, disfigurement, loss of function, potentially amputation.
- Signs/Symptoms:
- Blanching.
- Burning and discomfort.
- Cool skin.
- Swelling at/above IV site.
- Blistering and skin sloughing.
- Management:
- Same as infiltration.
- Administer antidote per facility protocol (e.g., hyaluronidase to increase tissue permeability and promote absorption).